Advance Seen in Turning Adult Cells Into Stem Cells

Israeli researchers find molecule that blocks the rapid transformation

  • Print

WEDNESDAY, Sept. 18 (HealthDay News) -- Scientists have figured out a way to more readily turn adult skin cells into primitive stem cells that could potentially be used to treat a variety of chronic diseases.

In a study published Sept. 18 in Nature, Israeli researchers reported that they identified the key molecule that stops adult cells from transforming into so-called induced pluripotent stem (iPS) cells. Those stem cells are similar to the primitive cells found in embryos, and have the potential to generate any type of body tissue, scientists believe.

Ultimately, the hope is to use iPS cells to treat damaged tissue in a range of chronic ills -- from heart disease and diabetes, to arthritis, and spinal cord injuries and Alzheimer's disease.

That's still some years away, according to the experts, but the new findings are a step forward.

"We've already known how to create these cells, but it's an inefficient process," said Konrad Hochedlinger, a stem cell researcher at Massachusetts General Hospital in Boston who was not involved in the study.

Right now, it could take weeks to months to coax human skin cells to transform into iPS cells. And even then, only a fraction of the cells are actually successfully "reprogrammed," Hochedlinger added.

In the new study, researchers reprogrammed in the space of one week nearly all of the mouse and human skin cells they studied.

They did it by identifying a molecule that normally acts as a "roadblock" to keep adult cells from reverting back to infancy.

"We uncovered a new major pathway that prevents skin cells from converting back to an embryonic state," said senior researcher Dr. Jacob Hanna, of the Weizmann Institute of Science in Rehovot, Israel.

"If we block this pathway, we increase current methods of making iPS cells up to 100 percent (efficiency), and eliminate the randomness and protracted nature of the process," he added.

Stem cells have been a hot topic in scientific research for years, with controversy swirling around the study of embryonic stem cells -- because that requires an embryo to be destroyed in the process. But in 2007, researchers had their first success with reprogramming adult human cells to become embryonic-like stem cells.

It's done by activating just a few key genes that override the identity of an adult cell and send it back to an embryonic-like state. But the process has been hampered by inefficiency, and, Hochedlinger said, "we didn't know why that was."

The new findings point the finger at a molecule called Mbd3. Hanna's team found that blocking its action allowed human skin cells to be transformed into iPS cells almost 100 percent of the time.

Right now, Hochedlinger noted, the most efficient way to convert adult cells into pluripotent stem cells is through a viral vector -- through which a virus is used to transport the necessary "reprogramming factors" into the cell.

The limitation is, the virus genetically alters the cell. And in animal research, that has been shown to sometimes cause cancer, according to the U.S. National Institutes of Health.

But this new process, Hochedlinger said, could make it easier for researchers to efficiently generate human iPS cells using virus-free techniques (which already exist).

Hanna stressed that point. "This is a major advance toward making safer iPS cells, without genetic modifications, at high efficiency," he said.

But another stem cell researcher said it remains to be seen whether iPS cells created this way really do have a low rate of "reprogramming errors" -- including activation of genes that could promote cancer.

It's not only viral vectors that introduce those errors into cells. The reprogramming process itself can do it, said Juan Dominguez-Bendala, of the Diabetes Research Institute at the University of Miami Miller School of Medicine.

"When a cell that has a specific function is forced to wipe out its memory and act as a stem cell, it has to activate genes that normally remain silent in adult cells," Dominguez-Bendala explained. Some of those genes, he said, are involved in controlling cell replication -- and cancer is essentially out-of-control cell growth.

"Since there is a very thin line between a stem cell and a cancer cell," Dominguez-Bendala added, "you want the (reprogramming) process to be as clean as possible."

The new method may indeed be "cleaner," he said, but that's just "conjecture" for now.

Still, both he and Hochedlinger said that for researchers, the new findings will help in sorting out exactly what goes on during cell reprogramming -- which will be important if iPS cells are to be used to treat diseases.

Just this summer, Japanese researchers received approval for the world's first clinical trial of iPS cell therapy -- to treat the age-related eye disease macular degeneration.

Hochedlinger said his guess is the therapy could become a reality for certain diseases within the next five to 10 years.

More information

The U.S. National Institutes of Health has a primer on stem cells.

Fact Check

Fact Check

Have you found an error, or know of something we’ve missed in one of our stories?
Please use the form below and let us know.

* Required
  • Please post the headline of the story or the title of the video with the error.

  • Please post exactly what was wrong with the story.

  • Please indicate your source for the correct information.

  • Yes


  • This will only be used to contact you if we have a question about your submission, it will not be used to identify you or be published.

  • Cancel

Having problems with the form?

Contact Us Directly
  • Print

You can comment on most stories on You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

You can comment on most stories on You can also agree or disagree with other comments. All you need to do is be a Winnipeg Free Press print or e-edition subscriber to join the conversation and give your feedback.

Have Your Say

New to commenting? Check out our Frequently Asked Questions.

Have Your Say

Comments are open to Winnipeg Free Press print or e-edition subscribers only. why?

Have Your Say

Comments are open to Winnipeg Free Press Subscribers only. why?

The Winnipeg Free Press does not necessarily endorse any of the views posted. By submitting your comment, you agree to our Terms and Conditions. These terms were revised effective April 16, 2010.


Make text: Larger | Smaller


Winnipeg Jet goalie Michael Hutchinson

View more like this

Photo Store Gallery

  • MIKE DEAL / WINNIPEG FREE PRESS 060711 Chris Pedersen breeds Monarch butterflies in his back yard in East Selkirk watching as it transforms from the Larva or caterpillar through the Chrysalis stage to an adult Monarch. Here an adult Monarch within an hour of it emerging from the Chrysalis which can be seen underneath it.
  • Winnipeg’s best friend the dragon fly takes a break at English Gardens in Assiniboine Park Wednesday- A dragon fly can eat  food equal to its own weight in 30 minutes-Standup photo- June 13, 2012   (JOE BRYKSA / WINNIPEG FREE PRESS)

View More Gallery Photos


What should the legal drinking age be?

View Results

View Related Story

Ads by Google